Abstract
To report on the incidence and use of kelp among patients with thyroid cancer. Data were collected using a web-based online anonymous survey under Institutional Review Board approval from Boston University. This report is based on 27 responses from subjects with thyroid cancer who use kelp. Demographic factors and complementary and alternative use were included. Respondents were primarily over age 40, white, female and have at least a high school education. The top five modalities were multivitamins, special diets, herbal supplements, prayer for health reasons and herbal tea. Only one patient reported perceiving a particular modality had a negative effect on treatment. Complementary and alternative medicine (CAM) was more often perceived as being used to aid their thyroid cancer treatment than to help with symptoms. On average, respondents who use kelp also use at least 11 additional CAM modalities. Only 1/2 of respondents who use kelp reported telling their physicians about their CAM use, and nearly 1/3 of respondents reported their CAM use was neither known, prescribed nor asked about by their physicians. In comparison to both national surveys of the general US population and patients with thyroid cancer, kelp users with thyroid cancer use at least twice the number of additional CAM therapies and report their use far less often. Physicians who treat patients with thyroid cancer should be aware of these data to further assist in their assessment and care.
Similar content being viewed by others
Abbreviations
- IRB:
-
Institutional Review Board
- CAM:
-
Complementary and alternative medicine
- US:
-
United States
- NCCAM:
-
National Center for Complementary and Alternative Medicine
- μg:
-
Micrograms
- TSH:
-
Thyroid-stimulating hormone
- TgAb:
-
Anti-thyroglobulin antibodies
- TG:
-
Thyroglobulin
- EBRT:
-
External beam radiation therapy
References
National Center for Complementary and Alternative Medicine Herbs at a Glance
F.W. Clements, Health significance of endemic goitre and related conditions. Monogr. Ser. World Health Organ. 44, 235–260 (1960)
J. Teas, S. Pino, A. Critchley, L.E. Braverman, Variability of iodine content in common commercially available edible seaweeds. Thyroid Off. J. Am. Thyroid Assoc. 14(10), 836–841 (2004). doi:10.1089/thy.2004.14.836
Institute of Medicine: Dietary Reference Intakes for Vitamin A, vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. (2001)
T. Michikawa, M. Inoue, T. Shimazu, N. Sawada, M. Iwasaki, S. Sasazuki, T. Yamaji, S. Tsugane, Seaweed consumption and the risk of thyroid cancer in women: the Japan Public Health Center-based Prospective Study. Eur. J. Cancer Prev. 21(3), 254–260 (2012). doi:10.1097/CEJ.0b013e32834a8042
S.M. Arum, X. He, L.E. Braverman, Excess iodine from an unexpected source. N. Engl. J. Med. 360(4), 424–426 (2009). doi:10.1056/NEJMc0807580
P. Smyth, G. Cloughley, C. Clarke, D. Smith, E. Burbridge, Iodine and differentiated thyroid cancer: pathogenetic and therapeutic implications. Hormones (Athens) 8(3), 192–198 (2009)
J. Teas, L.E. Braverman, M.S. Kurzer, S. Pino, T.G. Hurley, J.R. Hebert, Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women. J. Med. Food 10(1), 90–100 (2007). doi:10.1089/jmf.2005.056
B.A. Crawford, C.T. Cowell, P.J. Emder, D.L. Learoyd, E.L. Chua, J. Sinn, M.M. Jack, Iodine toxicity from soy milk and seaweed ingestion is associated with serious thyroid dysfunction. Med. J. Aust. 193(7), 413–415 (2010)
B.C. Eliason, Transient hyperthyroidism in a patient taking dietary supplements containing kelp. J. Am. Board Fam. Pract. 11(6), 478–480 (1998)
R.B. Saper, S.N. Kales, J. Paquin, M.J. Burns, D.M. Eisenberg, R.B. Davis, R.S. Phillips, Heavy metal content of ayurvedic herbal medicine products. J. Am. Med. Assoc. 292(23), 2868–2873 (2004). doi:10.1001/jama.292.23.2868
R.B. Saper, R.S. Phillips, A. Sehgal, N. Khouri, R.B. Davis, J. Paquin, V. Thuppil, S.N. Kales, Lead, mercury, and arsenic in US- and Indian-manufactured ayurvedic medicines sold via the internet. JAMA, J. Am. Med. Assoc. 300(8), 915–923 (2008). doi:10.1001/jama.300.8.915
A.M. Leung, L.E. Braverman, Iodine-induced thyroid dysfunction. Curr. Opin. Endocrinol. Diabetes Obes. 19(5), 414–419 (2012). doi:10.1097/MED.0b013e3283565bb2
C.D. Clark, B. Bassett, M.R. Burge, Effects of kelp supplementation on thyroid function in euthyroid subjects. Endocr. Pract. 9(5), 363–369 (2003)
K. Miyai, T. Tokushige, M. Kondo, Suppression of thyroid function during ingestion of seaweed “Kombu” (Laminaria japonoca) in normal Japanese adults. Endocr. J. 55(6), 1103–1108 (2008)
P.M. Barnes, B. Bloom, R.L. Nahin, Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep 10(12), 1–23 (2008)
J.M. Fouladbakhsh, M. Stommel, B.A. Given, C.W. Given, Predictors of use of complementary and alternative therapies among patients with cancer. Oncol. Nurs. Forum 32(6), 1115–1122 (2005). doi:10.1188/05.ONF.1115-1122
B. Cassileth, Gerson regimen. Oncology (Williston Park) 24(2), 201 (2010)
H.M. Park, S.Y. Kim, I.C. Jung, Y.W. Lee, C.K. Cho, H.S. Yoo, Integrative tumor board: a case report and discussion from East-West Cancer Center. Integr. Cancer Ther. 9(2), 236–245 (2010). doi:10.1177/1534735410371479
L.W. Corbin, B.K. Mellis, B.L. Beaty, J.S. Kutner, The use of complementary and alternative medicine therapies by patients with advanced cancer and pain in a hospice setting: a multicentered, descriptive study. J. Palliat. Med. 12(1), 7–8 (2009)
E. Ben-Arye, M. Frenkel, G. Bar-Sela, R.S. Margalit, D. Hermoni, A. Kuten, Teaching complementary medicine at an academic oncology department. J. Cancer Educ. 23(1), 46–50 (2008). doi:10.1080/08858190701821261
E. Ernst, Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Support. Care Cancer 17(4), 333–337 (2009)
C.L. Carpenter, P.A. Ganz, L. Bernstein, Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res. Treat. 116(2), 387–396 (2009)
J. Rosen, P. Gardiner, R.B. Saper, A. Filippelli, L.F. White, E.N. Pearce, R. Gupta-Lawrence, S.L. Lee, Complementary and alternative medicine use among patients with thyroid cancer. Thyroid Off. J. Am. Thyroid Assoc. (2013). doi:10.1089/thy.2012.0495
D.M. Eisenberg, R.C. Kessler, C. Foster, F.E. Norlock, D.R. Calkins, T.L. Delbanco, Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N. Engl. J. Med. 328(4), 246–252 (1993). doi:10.1056/NEJM199301283280406
K. Tasaki, G. Maskarinec, D.M. Shumay, Y. Tatsumura, H. Kakai, Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psycho-Oncology 11(3), 212–220 (2002). doi:10.1002/pon.552
M.H. Cohen, D.M. Eisenberg, Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann. Intern. Med. 136(8), 596–603 (2002)
K.J. Kemper, A. Amata-Kynvi, L. Dvorkin, J.S. Whelan, A. Woolf, R.C. Samuels, P. Hibberd, Herbs and other dietary supplements: healthcare professionals’ knowledge, attitudes, and practices. Altern. Ther. Health Med. 9(3), 42–49 (2003)
D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009). doi:10.1089/thy.2009.0110
N. Konno, H. Makita, K. Yuri, N. Iizuka, K. Kawasaki, Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J. Clin. Endocrinol. Metab. 78(2), 393–397 (1994)
Conflict interests
The author(s) declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosen, J.E., Gardiner, P., Saper, R.B. et al. Kelp use in patients with thyroid cancer. Endocrine 46, 123–130 (2014). https://doi.org/10.1007/s12020-013-0048-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0048-2